Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

NCT02988466 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

BIOLOGICAL: Haplo HCT <55 years old
BIOLOGICAL: Haplo HCT ≥55 years old
DRUG: GVHD Prophylaxis
BIOLOGICAL: Haplo HCT ≥55 and < 65 years old
BIOLOGICAL: Haplo HCT ≥65 and ≤75 years old

Sponsor

Masonic Cancer Center, University of Minnesota